Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind Study With Placebo to Verify the Efficacy, Safety and Tolerability of the Modified Isothymol or Carvacrol Compound Against the SARS-CoV-2 Agent in COVID-19 Patients

NCT05445089 is registered in ClinicalTrials.gov with Instituto Venezolano de Investigaciones Cientificas as lead sponsor.

NCT NCT05445089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05445089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind Study With Placebo to Verify the Efficacy, Safety and Tolerability of the Modified Isothymol or Carvacrol Compound Against the SARS-CoV-2 Agent in COVID-19 Patients
Lead sponsor
Instituto Venezolano de Investigaciones Cientificas
Phase
Phase 2/3
Overall status
Completed
Start date
August 1, 2020
Completion date
December 15, 2020
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, covid-19 acute respiratory distress syndrome, covid-19 lower respiratory infection, covid-19 pneumonia, covid-19 respiratory infection